Cargando…
Bioinformatics Analysis of Global Proteomic and Phosphoproteomic Data Sets Revealed Activation of NEK2 and AURKA in Cancers
Tumor heterogeneity attributes substantial challenges in determining the treatment regimen. Along with the conventional treatment, such as chemotherapy and radiotherapy, targeted therapy has greater impact in cancer management. Owing to the recent advancements in proteomics, we aimed to mine and re-...
Autores principales: | Deb, Barnali, Sengupta, Pratyay, Sambath, Janani, Kumar, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072708/ https://www.ncbi.nlm.nih.gov/pubmed/32033228 http://dx.doi.org/10.3390/biom10020237 |
Ejemplares similares
-
Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma
por: Deb, Barnali, et al.
Publicado: (2019) -
Global redox proteome and phosphoproteome analysis reveals redox switch in Akt
por: Su, Zhiduan, et al.
Publicado: (2019) -
Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer
por: George, Irene A., et al.
Publicado: (2022) -
Developmentally-Dynamic Murine Brain Proteomes and Phosphoproteomes Revealed by Quantitative Proteomics
por: Doubleday, Peter F., et al.
Publicado: (2014) -
Integrated pan‐cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance
por: Miralaei, Noushin, et al.
Publicado: (2021)